| Members |
targetComponentId |
| sténose postradique du méat acoustique externe |
Stenosis of external auditory canal caused by ionizing radiation |
| substance antimicrobienne |
agent antiviral |
| substance antimicrobienne |
Antibacterial |
| substance antimicrobienne |
Antiprotozoal |
| substance antimicrobienne |
Antifungal |
| Suicide of relative |
antécédents familiaux : suicide |
| Sulfamethoxazole and trimethoprim (substance) |
Trimethoprim (substance) |
| Sulfamethoxazole and trimethoprim (substance) |
Sulfamethoxazole (substance) |
| Atropine sulfate 1mg/1mL injection (product) |
Atropine sulfate 1 mg/mL solution for injection |
| Atropine sulfate 1.25mg/1mL injection (product) |
Atropine sulfate 1.25 mg/mL solution for injection |
| Atropine sulfate 3mg/10mL injection (product) |
Product containing precisely atropine sulfate 300 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Atropine sulfate 400micrograms/1mL injection (product) |
Atropine sulfate 400 microgram/mL solution for injection |
| Atropine sulfate 600micrograms/1mL injection (product) |
Product containing precisely atropine sulfate 600 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Protamine sulfate 100mg/10mL injection (product) |
Product containing precisely protamine sulfate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Protamine sulfate 50mg/5mL injection (product) |
Product containing precisely protamine sulfate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Terbutaline sulfate 2.5mg/5mL intravenous infusion (product) |
Product containing precisely terbutaline sulfate 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Terbutaline sulfate 500micrograms/1mL injection (product) |
Product containing precisely terbutaline sulfate 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Renal replacement (procedure) |
Transplant of kidney |
| Renal replacement (procedure) |
Continuous renal replacement therapy (procedure) |
| Enteral dietary supplement (substance) |
Edible substance (substance) |
| Unilateral deafness |
Deafness of right ear |
| Unilateral deafness |
Deafness of left ear (disorder) |
| Accidental sulfamethoxazole and trimethoprim overdose |
Accidental sulfamethoxazole and/or trimethoprim overdose (disorder) |
| Sulfamethoxazole and trimethoprim overdose |
Sulfamethoxazole and/or trimethoprim overdose (disorder) |
| Sulfamethoxazole and trimethoprim overdose of undetermined intent |
Sulfamethoxazole and/or trimethoprim overdose (disorder) |
| Intentional sulfamethoxazole and trimethoprim overdose |
Intentional sulfamethoxazole and/or trimethoprim overdose (disorder) |
| Day care/respite surveillance (regime/therapy) |
Day care surveillance (regime/therapy) |
| Day care/respite surveillance (regime/therapy) |
Respite care surveillance (regime/therapy) |
| Intrapartum monitoring of fetus with pulsed Doppler ultrasound |
échographie fœtale pour survaillance ante partum |
| Hepatitis a vaccine, inactiv 25unt suspension (product) |
Hepatitis A virus antigen-containing vaccine product |
| Hepatitis a vaccine, inactiv 50unt suspension (product) |
Hepatitis A virus antigen-containing vaccine product |
| symptôme mental |
Mental state finding |
| Meretoja syndrome (disorder) |
AGel amyloidosis |
| Moynahan's syndrome |
Multiple lentigines syndrome |
| Moynahan's syndrome |
Alopecia, epilepsy, intellectual disability syndrome Moynahan type |
| syndrome de Sjögren primaire avec atteinte multisystémique |
Sjögren's syndrome |
| Primary Sjögren's syndrome with organ/system involvement (disorder) |
Sjögren's syndrome |
| syndrome de Sjögren secondaire avec atteinte multisystémique |
Secondary Sjögren's syndrome (disorder) |
| Secondary Sjögren's syndrome with organ/system involvement (disorder) |
Secondary Sjögren's syndrome (disorder) |
| Pseudoclaudication syndrome |
Neurogenic claudication |
| AIDS-like syndrome |
trouble d'immunodéficience secondaire |
| AIDS-like syndrome |
AIDS |
| Uses supplies and equipment within safe parameters (procedure) |
Ensuring use of supplies and equipment within safe parameters (procedure) |
| Uses infusion pump within safe parameters (procedure) |
Ensuring use of infusion pump within safe parameters (procedure) |
| Late effect of external cause |
Late effect of injury |
| Late effect of homicide or assault (disorder) |
Late effects of assault |
| Late effect of homicide or assault (disorder) |
Late effect due to homicide attempt (disorder) |
| Sequelae of external causes and disorders (disorder) |
Sequela of disorder |
| Escherichia coli serotype (organism) |
Escherichia coli |
| Dihydrocodeine tartrate 50mg/mL injection solution 1mL ampule (product) |
Product containing precisely dihydrocodeine tartrate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Bagolini test (procedure) |
Bagolini striated glasses test (procedure) |
| Papanicolaou test |
Microscopic examination of cervical Papanicolaou smear (procedure) |
| Papanicolaou test |
Sampling of female genital tract for smear (procedure) |
| Papanicolaou test |
Sampling of cervix for Papanicolaou smear (procedure) |
| Papanicolaou test |
Microscopic examination of anal Papanicolaou smear (procedure) |
| Papanicolaou test |
Microscopic examination of vaginal Papanicolaou smear (procedure) |
| Papanicolaou test |
Sampling of vagina for Papanicolaou smear (procedure) |
| Histoplasmosis test negative |
Delayed hypersensitivity skin test for histoplasmin negative |
| Histoplasmosis test positive |
Delayed hypersensitivity skin test for histoplasmin positive |
| Unilateral undescended testis |
Undescended right testicle |
| Unilateral undescended testis |
Undescended left testicle |
| Other specified pulmonary tuberculosis |
Pulmonary tuberculosis (disorder) |
| Mesenteric thrombus and/or embolus |
Mesenteric embolus |
| Mesenteric thrombus and/or embolus |
Thrombosis of mesenteric artery |
| Mesenteric thrombus and/or embolus |
Thrombosis of mesenteric vein |
| thrombose veineuse profonde d'une jambe liée à l'administration d'un médicament par voie intraveineuse |
Deep vein thrombosis of lower extremity due to intravenous drug use (disorder) |
| thyroïdite auto-immune auto-limitante avec hyperthyroïdie transitoire et/ou hypothyroïdie |
hyperthyroïdie avec maladie d'Hashimoto (trouble) |
| thyroïdite auto-immune auto-limitante avec hyperthyroïdie transitoire et/ou hypothyroïdie |
hypothyroïdie due à la thyroïdite d'Hashimoto |
| Tinzaparin sodium 10,000iu/mL injection solution 2mL vial (product) |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Tinzaparin sodium 10,000iu/mL injection solution 0.25mL prefilled syringe (product) |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Tinzaparin sodium 10,000iu/mL injection solution 0.35mL prefilled syringe (product) |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Tinzaparin sodium 10,000iu/mL injection solution 0.45mL prefilled syringe (product) |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Tinzaparin sodium 20,000iu/mL injection solution 0.5mL prefilled syringe (product) |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Tinzaparin sodium 20,000iu/mL injection solution 0.7mL prefilled syringe (product) |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Tinzaparin sodium 20,000iu/mL injection solution 0.9mL prefilled syringe (product) |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Tinzaparin sodium 20,000iu/mL injection solution 2mL vial (product) |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Tobramycin 40mg/mL injection solution 1mL ampule (product) |
Product containing precisely tobramycin (as tobramycin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Tobramycin 40mg/mL injection solution 2mL ampule (product) |
Product containing precisely tobramycin (as tobramycin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| tomodensitométrie des systèmes |
tomodensitométrie |
| Bretylium tosylate 50mg/mL injection solution 10mL prefilled syringe (product) |
Product containing precisely bretylium tosylate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Toxoplasmosis associated with AIDS |
Infection caused by Toxoplasma gondii co-occurrent with acquired immunodeficiency syndrome (disorder) |
| Curative treatment |
à visée curative (valeur de l'attribut) |
| Palliative treatment |
Palliative procedure |
| Palliative treatment |
à visée palliative (valeur de l'attribut) |
| Other materials processor |
Metal processer |
| Other materials processor |
Materials processor excluding metal |
| Benign familial tremor |
Essential tremor |
| Benign familial tremor |
Hereditary essential tremor |
| Tropisetron 1mg/mL injection solution 2mL ampule (product) |
Product containing precisely tropisetron (as tropisetron hydrochloride) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Tropisetron 1mg/mL injection solution 5mL ampule (product) |
Product containing precisely tropisetron (as tropisetron hydrochloride) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Immune hypersensitivity disorder (disorder) |
Allergic condition |
| Aggressive type unsocialized behavior disorder |
Aggressive unsocial conduct disorder |
| Metabolic disorder following abortive pregnancy |
Induced termination of pregnancy complicated by metabolic disorder (disorder) |
| Eosinophilic disorder |
Eosinophil count raised (finding) |
| troubles du développement et de l'éruption dentaires |
Disorder of tooth development (disorder) |
| troubles du développement et de l'éruption dentaires |
Tooth eruption disorder (disorder) |
| troubles psychiques liés aux soins intensifs |
trouble mental organique |
| troubles psychiques liés aux soins intensifs |
trouble mental |
| Tuberculosis of the pelvic and/or thigh bones (disorder) |
Tuberculosis of pelvis and femur |
| Types of infections |
maladie infectieuse |
| Teicoplanin 200mg powder and solvent for injection solution vial (product) |
Product containing precisely teicoplanin 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
FHIR